A Self-complete Measure of Health Status for Chronic Airflow Limitation: The St. George's Respiratory Questionnaire

Jones, Paul; Quirk, Frances; Baveystock, C M; Littlejohns, Peter

doi:10.1164/ajrccm/145.6.1321

Cited by 2,735 publications

(2,135 citation statements)

References 4 publications

Supporting

Mentioning

1,985

Contrasting

Unclassified

Order By: Relevance

“…Higher scores indicate poorer health-related quality of life. The scores are calculated after filling in an Excel file developed by the creators of the questionnaire [24,25]. The SGRQ is a validated tool for patients with airflow limitations [24].…”

Section: Methodsmentioning

confidence: 99%

See 1 more Smart Citation

Validation of the COPD Assessment Test (CAT) in patients with idiopathic pulmonary fibrosis

Grufstedt

Shaker

Konradsen

2018

European Clinical Respiratory Journal

View full text Add to dashboard Cite

Introduction: Idiopathic pulmonary fibrosis (IPF) is a chronic disease with high morbidity and mortality. A reliable and manageable questionnaire that assesses patients’ quality of life is needed to help to improve the content of clinical consultations. The chronic obstructive pulmonary disease (COPD) Assessment Test (CAT) is used in clinical practice; therefore, the aim of this study was to investigate correlations among the CAT, St. George’s Respiratory Questionnaire (SGRQ) and clinical parameters among patients diagnosed with IPF.Methods: A retrospective cohort design was employed in which 87 patients diagnosed with IPF who were receiving treatment at an outpatient clinic were included.Results: The CAT was found to be significantly correlated with SGRQ (p < 0.001). Furthermore, the CAT was significantly correlated with all of the included physiological variables.Conclusions: This add to support the validity of the COPD Assessment test (CAT) as a measure of symptoms in patients with IPF which in clinical practice in combination with dialogue between healthcare professionals and the patient, can help to improve the content of a clinical consultation.

show abstract

Section: Methodsmentioning

confidence: 99%

“…The scores are calculated after filling in an Excel file developed by the creators of the questionnaire [24,25]. The SGRQ is a validated tool for patients with airflow limitations [24]. Swigris and colleagues reviewed the literature and found that the SGRQ was useful for measuring HRQL in patients with IPF [25].…”

Section: Methodsmentioning

confidence: 99%

Validation of the COPD Assessment Test (CAT) in patients with idiopathic pulmonary fibrosis

Grufstedt

Shaker

Konradsen

2018

European Clinical Respiratory Journal

View full text Add to dashboard Cite

show abstract

“…Two instruments were used to measure health-related quality of life, namely the St. George's Respiratory Questionnaire (SGRQ) [39], a disease-specific health status questionnaire, and the RAND-36 [40], a generic health status questionnaire. The SGRQ consists of 76 items that measure 3 components: 'symptoms' (problems caused by specific respiratory symptoms), 'activity' (restriction of activities by dyspnea) and 'impacts' (impact on everyday life caused by the disease) (reliability: test-retest correlation r 0.92) [39].…”

Section: Outcome Measuresmentioning

confidence: 99%

“…The SGRQ consists of 76 items that measure 3 components: 'symptoms' (problems caused by specific respiratory symptoms), 'activity' (restriction of activities by dyspnea) and 'impacts' (impact on everyday life caused by the disease) (reliability: test-retest correlation r 0.92) [39]. The RAND-36, which is a Dutch translation of the MOS 36-item Short-Form Health Survey [41], consists of nine subscales.…”

Section: Outcome Measuresmentioning

confidence: 99%

The effects of a lifestyle physical activity counseling program with feedback of a pedometer during pulmonary rehabilitation in patients with COPD: A pilot study

Blok

Greef

Hacken³

et al. 2006

Patient Education and Counseling

192

216

View full text Add to dashboard Cite

“…Health status and mood state were assessed at baseline by means of the St. George's Respiratory Questionnaire 12 (SGRQ) and the Hospital Anxiety and Depression (HAD) Scale, 13 respectively. The SGRQ is a well-validated measure of impaired health in COPD and consists of 3 component scores (symptoms, activity, and impacts) and a summary score calculated from the 3 components.…”

Section: Measurementsmentioning

confidence: 99%

Effects of Formoterol Inhaled Dry Powder on Exercise Performance in Chronic Obstructive Pulmonary Disease: A Single-Center, Randomized, Double-Blind, Placebo-Controlled, Crossover Study

Fuso¹,

Incalzi²,

Basso³

et al. 2003

Current Therapeutic Research

View full text Add to dashboard Cite

Background: Inhaled bronchodilators commonly are used to reduce the work of breathing in patients with chronic obstructive pulmonary disease (COPD). The effects of bronchodilators are assessed in terms of symptom relief and/or improvements in spirometric indices. However, disability in COPD patients also is related to determinants such as exercise tolerance, which cannot be predicted on the basis of respiratory function. The effect of bronchodilators, such as inhaled beta 2 -agonists, on exercise performance of COPD patients needs to be tested.Objective: This study investigated the effects of formoterol inhaled dry powder on exercise performance assessed using the shuttle walking test (SWT) in patients with mild to moderate COPD.Methods: Patients having COPD with mild to moderate airway obstruction performed a pulmonary function test and an SWT before and after inhalation, on 2 consecutive days, of formoterol 12 µg or placebo, given by dry powder inhaler, according to a double-blind, placebo-controlled, crossover study design. Breathlessness was measured using the Borg scale (BS) and a visual analog scale at baseline and after an SWT.Results: Twenty patients (15 men, 5 women; mean [SD] age, 65.95 [8.32] years) were included in the study. Forced expiratory volume in 1 second (FEV 1 ) (P ϭ 0.009), forced mid-expiratory flow (FEF 25-75 ) (P ϭ 0.011), and SWT (P ϭ 0.005) improved significantly more with formoterol than placebo. Breathlessness decreased with formoterol, but the difference compared with placebo was statistically significant only when measured using the BS (P ϭ 0.023). In the pooled placebo and formoterol tests, changes in the SWT were unrelated to changes in FEV 1 (r ϭ 0.18) and in FEF 25-75 (r ϭ 0.31). CURRENT THERAPEUTIC RESEARCH Conclusions:The results of this study showed that formoterol inhaled dry powder significantly improved exercise performance in patients with COPD and that this effect was at least partially independent of achieved bronchodilation. A larger cohort of patients should be studied and a more comprehensive protocol performed to verify whether the increase in exercise tolerance after administration of formoterol is related to a decrease in expiratory flow limitation during exercise and/or to systemic effects of the drug. Another issue to be clarified is whether the improvement in exercise capacity can significantly decrease disability in patients with severe COPD. (Curr Ther Res Clin Exp. 2003;64:317-326)

show abstract

A Self-complete Measure of Health Status for Chronic Airflow Limitation: The St. George's Respiratory Questionnaire

Cited by 2,735 publications

References 4 publications

Validation of the COPD Assessment Test (CAT) in patients with idiopathic pulmonary fibrosis

Validation of the COPD Assessment Test (CAT) in patients with idiopathic pulmonary fibrosis

The effects of a lifestyle physical activity counseling program with feedback of a pedometer during pulmonary rehabilitation in patients with COPD: A pilot study

Effects of Formoterol Inhaled Dry Powder on Exercise Performance in Chronic Obstructive Pulmonary Disease: A Single-Center, Randomized, Double-Blind, Placebo-Controlled, Crossover Study

Contact Info

Product

Resources

About